Bergsmark C, Kristensen VA, Sjåmo MB, Høivik ML, Anisdahl K(2026) Therapeutic drug monitoring in inflammatory bowel disease patients switching from intravenous to subcutaneous infliximab: insights from a prospective real-world study Scand J Gastroenterol, 61(6), 633-643 DOI 10.1080/00365521.2026.2645083, PubMed 41902476
Berset IP, Lerang F, Moum B, Jahnsen J, Grimstad T, Kristensen V, Wiig H, Aabrekk T, Ness-Jenssen E, Eskeland S, Melsom E, Von Volkmann H, Huppertz-Hauss G, Torp R, Hovlid Ø, Buset M, Riise G, Horvei G, Finjord T, Jelsness-Jørgensen LP, Olsen IC, Jahnsen FL, Myklebust TÅ, Mølsæter K, Hoff DAL, Lundin KEA(2026) Anti-TNF withdrawal or long-term treatment in ulcerative colitis (BIOSTOP): a multicentre open label, randomized controlled trial J Crohns Colitis, 20(8) DOI 10.1093/ecco-jcc/jjag110, PubMed 42557857
